Fujian Wanchen Biotechnology Co. Ltd (300972) — Capital Reinvestment Ratio
Fujian Wanchen Biotechnology Co. Ltd (300972) has a Capital Reinvestment Ratio of 0.02x as of December 2025, meaning it reinvests 0% of its operating cash flow (CN¥3.63 Billion) in capital expenditures (CN¥77.44 Million). See Fujian Wanchen Biotechnology Co. Ltd free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Fujian Wanchen Biotechnology Co. Ltd Capital Reinvestment Ratio (2019–2025)
This chart tracks Fujian Wanchen Biotechnology Co. Ltd's Capital Reinvestment Ratio across 7 annual periods.
Annual Capital Reinvestment Ratio for Fujian Wanchen Biotechnology Co. Ltd (2019–2025)
Year-by-year Capital Reinvestment Ratio for Fujian Wanchen Biotechnology Co. Ltd from 2019 to 2025. For live market cap and broader valuation context, see Fujian Wanchen Biotechnology Co. Ltd stock valuation.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.02x | CN¥3.63 Billion | CN¥77.44 Million | ▼ -84.5% |
| 2024 | 0.14x | CN¥848.35 Million | CN¥116.65 Million | ▼ -35.7% |
| 2023 | 0.21x | CN¥1.02 Billion | CN¥218.91 Million | ▼ -95.2% |
| 2022 | 4.49x | CN¥70.38 Million | CN¥316.34 Million | ▲ +968.4% |
| 2021 | 0.42x | CN¥98.82 Million | CN¥41.57 Million | ▲ +17.2% |
| 2020 | 0.36x | CN¥156.24 Million | CN¥56.10 Million | ▲ +60.2% |
| 2019 | 0.22x | CN¥177.28 Million | CN¥39.73 Million | — |